Miller v. Bristol-Myers Squibb Company et al, No. 1:2017cv00330 - Document 42 (N.D. Ind. 2017)

Court Description: OPINION AND ORDER directing plaintiff to file a supplemental jurisdictional statement on or before 8/23/17, setting forth the identity and citizenship ofeach of the partners of AstraZeneca Pharmaceuticals LP, tracing through all applicable layers of ownership. (cc: Zimmer, Welling, Clark, Steimle) Signed by Magistrate Judge Paul R Cherry on 8/7/17. (mlc) Modified on 8/7/2017 to include routing (mlc).

Download PDF
Miller v. Bristol-Myers Squibb Company et al Doc. 42 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA FORT WAYNE DIVISION MICHAEL MILLER, Plaintiff, v. BRISTOL-MYERS SQUIBB COMPANY, et al., Defendants. ) ) ) ) ) ) ) CAUSE NO. 1:17-CV-330-WCL-PRC OPINION AND ORDER Plaintiff Michael Miller filed a Complaint based on diversity jurisdiction pursuant to 28 U.S.C. § 1332(a). On August 4, 2017, the case was transferred to this Court. The Court must continuously police its subject matter jurisdiction. Hay v. Ind. State Bd. of Tax Comm’rs, 312 F.3d 876, 879 (7th Cir. 2002). As the party seeking to invoke federal diversity jurisdiction, Miller bears the burden of demonstrating that the requirement of complete diversity has been met. Chase v. Shop’n Save Warehouse Foods, Inc., 110 F.3d 424, 427 (7th Cir. 1997). Anything less can result in a dismissal. Mut. Assignment & Indem. Co. v. Lind-Waldock & Co., LLC, 364 F.3d 858, 861 (7th Cir. 2004). The complaint recites that Miller is a citizen of Indiana, that Defendant Bristol-Myers Squibb Company is a Delaware corporation with its principal place of business in New York, that Defendant McKeson Corporation is a Delaware corporation with its principal place of business in California, and that Defendant AstraZeneca Pharmaceuticals LP “is a Delaware limited partnership with its principal place of business [in Delaware].” (Compl. ¶ 10, ECF No. 1). The statement of citizenship is insufficient as to AstraZeneca Pharmaceuticals LP. “[F]or purposes of deciding whether a suit by or against a limited partnership satisfies the requirement of complete diversity of citizenship . . . the citizenship of all the limited partners, as well as of the Dockets.Justia.com general partner[s], counts.” Market St. Assocs. LP v. Frey, 941 F.2d 588, 589 (7th Cir. 1991) (citing Carden v. Arkoma Assocs., 494 U.S. 185 (1990)). Moreover, “the citizenship of unincorporated associations must be traced through however many layers of partners or members there may be.” Meyerson v. Showboat Marina Casino P’ship, 312 F.3d 318, 320 (7th Cir. 2002) (citations omitted). Therefore, the Court hereby ORDERS Plaintiff Michael Miller to FILE a Supplemental Jurisdictional Statement on or before August 23, 2017, setting forth the identity and citizenship of each of the partners of AstraZeneca Pharmaceuticals LP, tracing through all applicable layers of ownership. So ORDERED this 7th day of August, 2017. s/ Paul R. Cherry MAGISTRATE JUDGE PAUL R. CHERRY UNITED STATES DISTRICT COURT 2

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.